Acumen Pharmaceuticals (ABOS)'s 30-day implied volatility (IV30) was 88.1% at the close on October 30, 2026, down from 202.8% the day before, against a 52-week range of 51.1% to 256.6%. Its 20-day historical volatility was 90.4%.
Data as of October 30, 2026.